title: [Diagnostic procedure combination in gastric cancer treatment].
abstract: Present status and problems in diagnostic procedure combination (DPC) for treatment of gastric cancer are reviewed in this article. DPC for gastric malignancies are subgrouped by the presence or absence of operation, operative procedures and adjuvant treatment such as intensive care, radiotherapy and chemotherapy. In a comparison between prospective payment and medical cost invested, most investments can be recovered by DPC in patients who underwent mucosal resection or gastrectomy without major complications. However, in patients with postoperative complications who required intensive treatment,considerable investments can not be recovered by DPC. In patients given chemotherapy, most of the investments in conventional chemotherapy can be recovered by current DPC. The clinical pathway appears to be a useful tool to control homogeneously well-qualified investments in DPC.
authors.affiliation: Dept. of Surgery 1, Fukushima Medical University.
authors.forename: Masanori
authors.initials: M
authors.lastname: Terashima
authors.forename: Zenichiro
authors.initials: Z
authors.lastname: Saze
authors.forename: Mitsukazu
authors.initials: M
authors.lastname: Gotoh
authors.forename: Susumu
authors.initials: S
authors.lastname: Yamatani
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019091:Critical Pathways; D003953:Diagnosis-Related Groups; D005743:Gastrectomy / Q000379:methods; D005773:Gastroscopy; D006801:Humans; D007902:Length of Stay; D011787:Quality of Health Care; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*